Artivion, Inc. is a global medical device company focused on technologies for aortic repair and cardiac surgery. Headquartered in Kennesaw, Georgia, USA, and listed on the New York Stock Exchange (AORT), the company develops and manufactures products used by cardiothoracic and vascular surgeons worldwide. Formerly known as CryoLife, it adopted the Artivion name in 2022.
Artivion’s portfolio includes solutions for open and endovascular aortic repair (such as stent grafts and surgical vascular grafts), mechanical heart valve technologies (including On-X valves), surgical adhesives/sealants for cardiovascular procedures, and related delivery systems and accessories. The company operates R&D and manufacturing in the United States and Europe and distributes its products through direct and partner channels in major healthcare markets. With devices that rely on advanced polymers, textiles, and biomaterials, Artivion is a relevant stakeholder at the interface of healthcare and specialty materials.